National Research Corporation (NASDAQ:NRCIA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

According to Zacks, “National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska. “

Shares of National Research Corporation (NASDAQ NRCIA) opened at 30.80 on Friday. The firm has a market cap of $748.41 million, a price-to-earnings ratio of 33.92 and a beta of 1.70. The stock has a 50 day moving average of $28.58 and a 200 day moving average of $23.31. National Research Corporation has a 12 month low of $14.35 and a 12 month high of $32.60.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/11/national-research-corporation-nasdaqnrcia-stock-rating-lowered-by-zacks-investment-research.html.

Large investors have recently modified their holdings of the stock. Citigroup Inc. boosted its stake in shares of National Research Corporation by 120.2% in the second quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock worth $224,000 after buying an additional 4,531 shares during the last quarter. Strs Ohio boosted its stake in shares of National Research Corporation by 210.3% in the second quarter. Strs Ohio now owns 12,100 shares of the business services provider’s stock worth $325,000 after buying an additional 8,200 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of National Research Corporation by 5.1% in the second quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock worth $333,000 after buying an additional 600 shares during the last quarter. Algert Global LLC acquired a new stake in shares of National Research Corporation during the second quarter worth approximately $384,000. Finally, Rice Hall James & Associates LLC boosted its stake in shares of National Research Corporation by 1.0% in the second quarter. Rice Hall James & Associates LLC now owns 15,035 shares of the business services provider’s stock worth $404,000 after buying an additional 155 shares during the last quarter. 28.44% of the stock is currently owned by hedge funds and other institutional investors.

Get a free copy of the Zacks research report on National Research Corporation (NRCIA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with MarketBeat.com's FREE daily email newsletter.